Tabuteau Herriot
Axsome Therapeutics, Inc. · Chief Executive Officer
Tabuteau Herriot is listed in filings as Chief Executive Officer at Axsome Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 9, 2026, including sale activity. Recent filings connect the profile to Axsome Therapeutics, Inc. (AXSM). The current snapshot covers public activity from Feb 25, 2025 to Jun 9, 2026. Reported amounts are shown as $12.0M to $4.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.